Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

94 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Validation of the Labcorp Plasma Focus Test to Facilitate Precision Oncology Through Cell-Free DNA Genomic Profiling of Solid Tumors.
Verner EL, Jackson JB, Severson E, Valkenburg KC, Greer AE, Riley DR, Sausen M, Maddox C, McGregor PM 3rd, Karandikar A, Hastings SB, Previs RA, Reddy VP, Jensen TJ, Ramkissoon SH. Verner EL, et al. Among authors: previs ra. J Mol Diagn. 2023 Jul;25(7):477-489. doi: 10.1016/j.jmoldx.2023.03.008. Epub 2023 Apr 15. J Mol Diagn. 2023. PMID: 37068734 Free article.
RNA Sequencing Identifies Novel NRG1 Fusions in Solid Tumors that Lack Co-Occurring Oncogenic Drivers.
Severson E, Achyut BR, Nesline M, Pabla S, Previs RA, Kannan G, Chenn A, Zhang S, Klein R, Conroy J, Sausen M, Sathyan P, Saini KS, Ghosh A, Jensen TJ, Reddy P, Ramkissoon SH. Severson E, et al. Among authors: previs ra. J Mol Diagn. 2023 Jul;25(7):454-466. doi: 10.1016/j.jmoldx.2023.03.011. Epub 2023 May 8. J Mol Diagn. 2023. PMID: 37164276 Free article.
Recent Advances in Gynecological Malignancies: Focus on ASCO 2023.
Bodriagova O, Previs RA, Gaba L, Shankar A, Vidal L, Saini KS. Bodriagova O, et al. Among authors: previs ra. Oncol Ther. 2023 Dec;11(4):397-409. doi: 10.1007/s40487-023-00244-5. Epub 2023 Sep 15. Oncol Ther. 2023. PMID: 37715082 Free PMC article. No abstract available.
Case report: Single gene testing and comprehensive genomic profiling in non-small cell lung cancer-a case series of divergent results from a large reference laboratory.
Strickland KC, Nesline MK, Previs RA, Ko H, Cooper M, Rushton JR, Wallen ZD, Pabla S, Conroy JM, Sausen M, Saini KS, Cantini L, Jensen TJ, Caveney BJ, Eisenberg M, Severson EA, Ramkissoon S. Strickland KC, et al. Among authors: previs ra. Front Oncol. 2024 Oct 31;14:1445668. doi: 10.3389/fonc.2024.1445668. eCollection 2024. Front Oncol. 2024. PMID: 39544293 Free PMC article.
A consensus-based classification workflow to determine genetically inferred ancestry from comprehensive genomic profiling of patients with solid tumors.
Wallen ZD, Nesline MK, Pabla S, Gao S, Vanroey E, Hastings SB, Ko H, Strickland KC, Previs RA, Zhang S, Conroy JM, Jensen TJ, George E, Eisenberg M, Caveney B, Sathyan P, Ramkissoon S, Severson EA. Wallen ZD, et al. Among authors: previs ra. Brief Bioinform. 2024 Sep 23;25(6):bbae557. doi: 10.1093/bib/bbae557. Brief Bioinform. 2024. PMID: 39471413 Free PMC article.
Comprehensive Assessment of Immune Phenotype and Its Effects on Survival Outcomes in HER2-Low versus HER2-Zero Breast Cancer.
Ko HC, Seager RJ, Pabla S, Senosain MF, Van Roey E, Gao S, Strickland KC, Previs RA, Green MF, Cooper M, Nesline MK, Hastings SB, Amoah KA, Zhang S, Conroy JM, Jensen TJ, Eisenberg M, Caveney B, Severson EA, Ramkissoon S, Gandhi S. Ko HC, et al. Among authors: previs ra. Breast Cancer (Dove Med Press). 2024 Aug 23;16:483-495. doi: 10.2147/BCTT.S476394. eCollection 2024. Breast Cancer (Dove Med Press). 2024. PMID: 39192887 Free PMC article.
94 results